Global Monoclonal Antibodies Industry Research Report, Growth Trends and Competitive Analysis 2022-2028

Publisher Name :
Date: 08-Nov-2022
No. of pages: 101
Inquire Before Buying

Report Scope

This latest report researches the industry structure, sales, revenue, price and gross margin. Major producers' production locations, market shares, industry ranking and profiles are presented. The primary and secondary research is done in order to access up-to-date government regulations, market information and industry data. Data were collected from the Monoclonal Antibodies manufacturers, distributors, end users, industry associations, governments' industry bureaus, industry publications, industry experts, third party database, and our in-house databases.

This report also includes a discussion of the major players across each regional Monoclonal Antibodies market. Further, it explains the major drivers and regional dynamics of the global Monoclonal Antibodies market and current trends within the industry.

Key Companies Covered

In this section of the report, the researchers have done a comprehensive analysis of the prominent players operating and the strategies they are focusing on to combat the intense competition. Company profiles and market share analysis of the prominent players are also provided in this section. Additionally, the specialists have done an all-encompassing analysis of each player. They have also provided reliable sales, revenue, price, market share and rank data of the manufacturers for the period 2017-2022. With the assistance of this report, key players, stakeholders, and other participants will be able to stay abreast of the recent and upcoming developments in the business, further enabling them to make efficient choices. Mentioned below are the prime players taken into account in this research report:

- Biocon

- Celltrion

- Dr. Reddy's Laboratories

- Hospira

- 3SBio

- Accord Healthcare

- AET Biotech

- Allergan

- Amega Biotech

Market Segments

This report has explored the key segments: by Type and by Application. The lucrativeness and growth potential have been looked into by the industry experts in this report. This report also provides sales, revenue and average price forecast data by type and by application segments based on sales, price, and value for the period 2017-2028.

Monoclonal Antibodies Segment by Type

- Erythropoietin (EPO)

- Human Growth Hormone (HGH)

- Granulocyte- Colony Stimulating Factor (G-CSF)

- Monoclonal Antibody (mAb)

- Insulin

- Interferon (IFN)

- Others

Monoclonal Antibodies Segment by Application

- Anti-Cancer

- Anti-Inflammatory/Autoimmune

Key Regions & Countries

This section of the report provides key insights regarding various regions and the key players operating in each region. Economic, social, environmental, technological, and political factors have been taken into consideration while assessing the growth of the particular region/country. The readers will also get their hands on the value and sales data of each region and country for the period 2017-2028.

- North America

- - U.S.

- - Canada

- Europe

- - Germany

- - France

- - U.K.

- - Italy

- - Russia

- Asia-Pacific

- - China

- - Japan

- - South Korea

- - India

- - Australia

- - Taiwan

- - Indonesia

- - Thailand

- - Malaysia

- - Philippines

- - Vietnam

- Latin America

- - Mexico

- - Brazil

- - Argentina

- Middle East & Africa

- - Turkey

- - Saudi Arabia

- - U.A.E

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

COVID-19 and Russia-Ukraine War Influence Analysis

The readers in the section will understand how the Monoclonal Antibodies market scenario changed across the globe during the pandemic, post-pandemic and Russia-Ukraine War. The study is done keeping in view the changes in aspects such as demand, consumption, transportation, consumer behavior, supply chain management, export and import, and production. The industry experts have also highlighted the key factors that will help create opportunities for players and stabilize the overall industry in the years to come.

Report Includes:

This report presents an overview of global market for Monoclonal Antibodies, sales, revenue and price. Analyses of the global market trends, with historic market revenue/sales data for 2017 - 2021, estimates for 2022, and projections of CAGR through 2028.

This report researches the key producers of Monoclonal Antibodies, also provides the sales of main regions and countries. Highlights of the upcoming market potential for Monoclonal Antibodies, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Monoclonal Antibodies sales, revenue, market share and industry ranking of main manufacturers, data from 2017 to 2022. Identification of the major stakeholders in the global Monoclonal Antibodies market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by type and by application, sales, revenue, and price, from 2017 to 2028. Evaluation and forecast the market size for Monoclonal Antibodies sales, projected growth trends, production technology, application and end-user industry.

Descriptive company profiles of the major global players, including Biocon, Celltrion, Dr. Reddy's Laboratories, Hospira, 3SBio, Accord Healthcare, AET Biotech, Allergan and Amega Biotech, etc.

Global Monoclonal Antibodies Industry Research Report, Growth Trends and Competitive Analysis 2022-2028

Table of Contents
1 Report Overview
1.1 Research Scope
1.2 Market Segment by Type
1.2.1 Global Monoclonal Antibodies Market Size Growth Rate by Type (2017 VS 2021 VS 2028)
1.2.2 Erythropoietin (EPO)
1.2.3 Human Growth Hormone (HGH)
1.2.4 Granulocyte- Colony Stimulating Factor (G-CSF)
1.2.5 Monoclonal Antibody (mAb)
1.2.6 Insulin
1.2.7 Interferon (IFN)
1.2.8 Others
1.3 Market Segment by Application
1.3.1 Global Monoclonal Antibodies Market Share by Application (2017 VS 2021 VS 2028)
1.3.2 Anti-Cancer
1.3.3 Anti-Inflammatory/Autoimmune
1.4 Study Objectives
1.5 Years Considered
2 Market Perspective
2.1 Global Monoclonal Antibodies Market Size (2017-2028)
2.1.1 Global Monoclonal Antibodies Revenue (2017-2028)
2.1.2 Global Monoclonal Antibodies Sales (2017-2028)
2.2 Global Monoclonal Antibodies Market Size across Key Geographies Worldwide: 2017 VS 2021 VS 2028
2.2.1 Global Monoclonal Antibodies Sales by Regions (2017-2022)
2.2.2 Global Monoclonal Antibodies Revenue by Regions (2017-2022)
2.3 Global Monoclonal Antibodies Market Size Forecast by Region
2.3.1 Global Monoclonal Antibodies Sales Forecast by Region (2023-2028)
2.3.2 Global Monoclonal Antibodies Revenue Forecast by Region (2023-2028)
2.4 Global Top Monoclonal Antibodies Regions (Countries) Ranking by Market Size
2.5 Monoclonal Antibodies Market Dynamics
2.5.1 Monoclonal Antibodies Market Trends
2.5.2 Monoclonal Antibodies Market Drivers
2.5.3 Monoclonal Antibodies Market Challenges
2.5.4 Monoclonal Antibodies Market Restraints
3 Competitive Landscape by Manufacturers
3.1 Global Top Monoclonal Antibodies Manufacturers by Sales (2017-2022)
3.1.1 Global Monoclonal Antibodies Sales by Manufacturers (2017-2022)
3.1.2 Global Monoclonal Antibodies Sales Market Share by Manufacturers (2017-2022)
3.1.3 Global 5 and 10 Largest Manufacturers by Monoclonal Antibodies Sales in 2021
3.2 Global Top Manufacturers Monoclonal Antibodies by Revenue
3.2.1 Global Monoclonal Antibodies Revenue by Manufacturers (2017-2022)
3.2.2 Top Monoclonal Antibodies Manufacturers Covered: Ranking by Revenue
3.2.3 Global Monoclonal Antibodies Revenue Share by Manufacturers (2017-2022)
3.2.4 Global Monoclonal Antibodies Market Concentration Ratio (CR5 and HHI)
3.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Monoclonal Antibodies as of 2021)
3.4 Global Monoclonal Antibodies Average Selling Price (ASP) by Manufacturers
3.5 Key Manufacturers Monoclonal Antibodies Plants/Factories Distribution and Area Served
3.6 Date of Key Manufacturers Enter into Monoclonal Antibodies Market
3.7 Key Manufacturers Monoclonal Antibodies Product Offered
3.8 Mergers & Acquisitions, Expansion Plans
4 Global Monoclonal Antibodies Market Size by Type
4.1 Global Monoclonal Antibodies Historic Market Review by Type (2017-2022)
4.1.1 Global Monoclonal Antibodies Sales Market Share by Type (2017-2022)
4.1.2 Global Monoclonal Antibodies Revenue Market Share by Type (2017-2022)
4.1.3 Monoclonal Antibodies Price by Type (2017-2022)
4.2 Global Monoclonal Antibodies Market Estimates and Forecasts by Type (2023-2028)
4.2.1 Global Monoclonal Antibodies Sales Forecast by Type (2023-2028)
4.2.2 Global Monoclonal Antibodies Revenue Forecast by Type (2023-2028)
4.2.3 Monoclonal Antibodies Price Forecast by Type (2023-2028)
5 Global Monoclonal Antibodies Market Size by Application
5.1 Global Monoclonal Antibodies Historic Market Review by Application (2017-2022)
5.1.1 Global Monoclonal Antibodies Sales Market Share by Application (2017-2022)
5.1.2 Global Monoclonal Antibodies Revenue Market Share by Application (2017-2022)
5.1.3 Monoclonal Antibodies Price by Application (2017-2022)
5.2 Global Monoclonal Antibodies Market Estimates and Forecasts by Application (2023-2028)
5.2.1 Global Monoclonal Antibodies Sales Forecast by Application (2023-2028)
5.2.2 Global Monoclonal Antibodies Revenue Forecast by Application (2023-2028)
5.2.3 Monoclonal Antibodies Price Forecast by Application (2023-2028)
6 North America
6.1 North America Monoclonal Antibodies Sales Breakdown by Company
6.1.1 North America Monoclonal Antibodies Sales by Company (2017-2022)
6.1.2 North America Monoclonal Antibodies Revenue by Company (2017-2022)
6.2 North America Monoclonal Antibodies Market Size by Type
6.2.1 North America Monoclonal Antibodies Sales by Type (2017-2028)
6.2.2 North America Monoclonal Antibodies Revenue by Type (2017-2028)
6.3 North America Monoclonal Antibodies Market Size by Application
6.3.1 North America Monoclonal Antibodies Sales by Application (2017-2028)
6.3.2 North America Monoclonal Antibodies Revenue by Application (2017-2028)
6.4 North America Monoclonal Antibodies Market Size by Country
6.4.1 North America Monoclonal Antibodies Sales by Country (2017-2028)
6.4.2 North America Monoclonal Antibodies Revenue by Country (2017-2028)
6.4.3 U.S.
6.4.4 Canada
7 Europe
7.1 Europe Monoclonal Antibodies Sales Breakdown by Company
7.1.1 Europe Monoclonal Antibodies Sales by Company (2017-2022)
7.1.2 Europe Monoclonal Antibodies Revenue by Company (2017-2022)
7.2 Europe Monoclonal Antibodies Market Size by Type
7.2.1 Europe Monoclonal Antibodies Sales by Type (2017-2028)
7.2.2 Europe Monoclonal Antibodies Revenue by Type (2017-2028)
7.3 Europe Monoclonal Antibodies Market Size by Application
7.3.1 Europe Monoclonal Antibodies Sales by Application (2017-2028)
7.3.2 Europe Monoclonal Antibodies Revenue by Application (2017-2028)
7.4 Europe Monoclonal Antibodies Market Size by Country
7.4.1 Europe Monoclonal Antibodies Sales by Country (2017-2028)
7.4.2 Europe Monoclonal Antibodies Revenue by Country (2017-2028)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
8 Asia Pacific
8.1 Asia Pacific Monoclonal Antibodies Sales Breakdown by Company
8.1.1 Asia Pacific Monoclonal Antibodies Sales by Company (2017-2022)
8.1.2 Asia Pacific Monoclonal Antibodies Revenue by Company (2017-2022)
8.2 Asia Pacific Monoclonal Antibodies Market Size by Type
8.2.1 Asia Pacific Monoclonal Antibodies Sales by Type (2017-2028)
8.2.2 Asia Pacific Monoclonal Antibodies Revenue by Type (2017-2028)
8.3 Asia Pacific Monoclonal Antibodies Market Size by Application
8.3.1 Asia Pacific Monoclonal Antibodies Sales by Application (2017-2028)
8.3.2 Asia Pacific Monoclonal Antibodies Revenue by Application (2017-2028)
8.4 Asia Pacific Monoclonal Antibodies Market Size by Region
8.4.1 Asia Pacific Monoclonal Antibodies Sales by Region
8.4.2 Asia Pacific Monoclonal Antibodies Revenue by Region
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 India
8.4.7 Australia
8.4.8 Taiwan
8.4.9 Indonesia
8.4.10 Thailand
8.4.11 Malaysia
8.4.12 Philippines
8.4.13 Vietnam
9 Latin America
9.1 Latin America Monoclonal Antibodies Sales Breakdown by Company
9.1.1 Latin America Monoclonal Antibodies Sales by Company (2017-2022)
9.1.2 Latin America Monoclonal Antibodies Revenue by Company (2017-2022)
9.2 Latin America Monoclonal Antibodies Market Size by Type
9.2.1 Latin America Monoclonal Antibodies Sales by Type (2017-2028)
9.2.2 Latin America Monoclonal Antibodies Revenue by Type (2017-2028)
9.3 Latin America Monoclonal Antibodies Market Size by Application
9.3.1 Latin America Monoclonal Antibodies Sales by Application (2017-2028)
9.3.2 Latin America Monoclonal Antibodies Revenue by Application (2017-2028)
9.4 Latin America Monoclonal Antibodies Market Size by Country
9.4.1 Latin America Monoclonal Antibodies Sales by Country (2017-2028)
9.4.2 Latin America Monoclonal Antibodies Revenue by Country (2017-2028)
9.4.3 Mexico
9.4.4 Brazil
9.4.5 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Monoclonal Antibodies Sales Breakdown by Company
10.1.1 Middle East and Africa Monoclonal Antibodies Sales by Company (2017-2022)
10.1.2 Middle East and Africa Monoclonal Antibodies Revenue by Company (2017-2022)
10.2 Middle East and Africa Monoclonal Antibodies Market Size by Type
10.2.1 Middle East and Africa Monoclonal Antibodies Sales by Type (2017-2028)
10.2.2 Middle East and Africa Monoclonal Antibodies Revenue by Type (2017-2028)
10.3 Middle East and Africa Monoclonal Antibodies Market Size by Application
10.3.1 Middle East and Africa Monoclonal Antibodies Sales by Application (2017-2028)
10.3.2 Middle East and Africa Monoclonal Antibodies Revenue by Application (2017-2028)
10.4 Middle East and Africa Monoclonal Antibodies Market Size by Country
10.4.1 Middle East and Africa Monoclonal Antibodies Sales by Country (2017-2028)
10.4.2 Middle East and Africa Monoclonal Antibodies Revenue by Country (2017-2028)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 U.A.E
11 Company Profiles
11.1 Biocon
11.1.1 Biocon Corporation Information
11.1.2 Biocon Overview
11.1.3 Biocon Monoclonal Antibodies Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2017-2022)
11.1.4 Biocon Monoclonal Antibodies Products and Services
11.1.5 Biocon Monoclonal Antibodies SWOT Analysis
11.1.6 Biocon Recent Developments
11.2 Celltrion
11.2.1 Celltrion Corporation Information
11.2.2 Celltrion Overview
11.2.3 Celltrion Monoclonal Antibodies Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2017-2022)
11.2.4 Celltrion Monoclonal Antibodies Products and Services
11.2.5 Celltrion Monoclonal Antibodies SWOT Analysis
11.2.6 Celltrion Recent Developments
11.3 Dr. Reddy's Laboratories
11.3.1 Dr. Reddy's Laboratories Corporation Information
11.3.2 Dr. Reddy's Laboratories Overview
11.3.3 Dr. Reddy's Laboratories Monoclonal Antibodies Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2017-2022)
11.3.4 Dr. Reddy's Laboratories Monoclonal Antibodies Products and Services
11.3.5 Dr. Reddy's Laboratories Monoclonal Antibodies SWOT Analysis
11.3.6 Dr. Reddy's Laboratories Recent Developments
11.4 Hospira
11.4.1 Hospira Corporation Information
11.4.2 Hospira Overview
11.4.3 Hospira Monoclonal Antibodies Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2017-2022)
11.4.4 Hospira Monoclonal Antibodies Products and Services
11.4.5 Hospira Monoclonal Antibodies SWOT Analysis
11.4.6 Hospira Recent Developments
11.5 3SBio
11.5.1 3SBio Corporation Information
11.5.2 3SBio Overview
11.5.3 3SBio Monoclonal Antibodies Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2017-2022)
11.5.4 3SBio Monoclonal Antibodies Products and Services
11.5.5 3SBio Monoclonal Antibodies SWOT Analysis
11.5.6 3SBio Recent Developments
11.6 Accord Healthcare
11.6.1 Accord Healthcare Corporation Information
11.6.2 Accord Healthcare Overview
11.6.3 Accord Healthcare Monoclonal Antibodies Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2017-2022)
11.6.4 Accord Healthcare Monoclonal Antibodies Products and Services
11.6.5 Accord Healthcare Monoclonal Antibodies SWOT Analysis
11.6.6 Accord Healthcare Recent Developments
11.7 AET Biotech
11.7.1 AET Biotech Corporation Information
11.7.2 AET Biotech Overview
11.7.3 AET Biotech Monoclonal Antibodies Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2017-2022)
11.7.4 AET Biotech Monoclonal Antibodies Products and Services
11.7.5 AET Biotech Monoclonal Antibodies SWOT Analysis
11.7.6 AET Biotech Recent Developments
11.8 Allergan
11.8.1 Allergan Corporation Information
11.8.2 Allergan Overview
11.8.3 Allergan Monoclonal Antibodies Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2017-2022)
11.8.4 Allergan Monoclonal Antibodies Products and Services
11.8.5 Allergan Monoclonal Antibodies SWOT Analysis
11.8.6 Allergan Recent Developments
11.9 Amega Biotech
11.9.1 Amega Biotech Corporation Information
11.9.2 Amega Biotech Overview
11.9.3 Amega Biotech Monoclonal Antibodies Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2017-2022)
11.9.4 Amega Biotech Monoclonal Antibodies Products and Services
11.9.5 Amega Biotech Monoclonal Antibodies SWOT Analysis
11.9.6 Amega Biotech Recent Developments
12 Value Chain and Sales Channels Analysis
12.1 Monoclonal Antibodies Value Chain Analysis
12.2 Monoclonal Antibodies Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Monoclonal Antibodies Production Mode & Process
12.4 Monoclonal Antibodies Sales and Marketing
12.4.1 Monoclonal Antibodies Sales Channels
12.4.2 Monoclonal Antibodies Distributors
12.5 Monoclonal Antibodies Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer
List of Tables
Table 1. Global Monoclonal Antibodies Market Size Growth Rate by Type, 2017 VS 2021 VS 2028 (US$ Million)
Table 2. Major Manufacturers of Erythropoietin (EPO)
Table 3. Major Manufacturers of Human Growth Hormone (HGH)
Table 4. Major Manufacturers of Granulocyte- Colony Stimulating Factor (G-CSF)
Table 5. Major Manufacturers of Monoclonal Antibody (mAb)
Table 6. Major Manufacturers of Insulin
Table 7. Major Manufacturers of Interferon (IFN)
Table 8. Major Manufacturers of Others
Table 9. Global Monoclonal Antibodies Market Size Growth Rate by Application, 2017 VS 2021 VS 2028 (US$ Million)
Table 10. Global Monoclonal Antibodies Market Size (US$ Million) by Region: 2017 VS 2021 VS 2028
Table 11. Global Monoclonal Antibodies Sales by Region (2017-2022) & (K Units)
Table 12. Global Monoclonal Antibodies Sales Market Share by Region (2017-2022)
Table 13. Global Monoclonal Antibodies Revenue by Region (2017-2022) & (US$ Million)
Table 14. Global Monoclonal Antibodies Revenue Market Share by Region (2017-2022)
Table 15. Global Monoclonal Antibodies Sales Forecast by Region (2023-2028) & (K Units)
Table 16. Global Monoclonal Antibodies Sales Market Share Forecast by Region (2023-2028)
Table 17. Global Monoclonal Antibodies Revenue Forecast by Region (2023-2028) & (US$ Million)
Table 18. Global Monoclonal Antibodies Revenue Market Share Forecast by Region (2023-2028)
Table 19. Top Monoclonal Antibodies Regions (Countries) Ranking by Market Size (US$ Million) in 2021
Table 20. Monoclonal Antibodies Market Trends
Table 21. Monoclonal Antibodies Market Drivers
Table 22. Monoclonal Antibodies Market Challenges
Table 23. Monoclonal Antibodies Market Restraints
Table 24. Global Monoclonal Antibodies Sales by Manufacturers (2017-2022) & (K Units)
Table 25. Global Monoclonal Antibodies Sales Share by Manufacturers (2017-2022)
Table 26. Global Monoclonal Antibodies Revenue by Manufacturers (2017-2022) & (US$ Million)
Table 27. Ranking of Global Top Monoclonal Antibodies Manufacturers by Revenue (US$ Million) in 2021
Table 28. Monoclonal Antibodies Revenue Share by Manufacturers (2017-2022)
Table 29. Global Monoclonal Antibodies Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 30. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Monoclonal Antibodies as of 2021)
Table 31. Key Manufacturers Monoclonal Antibodies Average Selling Price (ASP) & (2017-2022) & (USD/Unit)
Table 32. Key Manufacturers Monoclonal Antibodies Plants/Factories Distribution
Table 33. Key Manufacturers Monoclonal Antibodies Area Served
Table 34. Date of Key Manufacturers Enter into Monoclonal Antibodies Market
Table 35. Key Manufacturers Monoclonal Antibodies Product Type
Table 36. Mergers & Acquisitions, Expansion Plans
Table 37. Global Monoclonal Antibodies Sales (K Units) by Type (2017-2022)
Table 38. Global Monoclonal Antibodies Sales Share by Type (2017-2022)
Table 39. Global Monoclonal Antibodies Revenue (US$ Million) Market Share by Type (2017-2022)
Table 40. Global Monoclonal Antibodies Price (K Units) by Type (2017-2022)
Table 41. Global Monoclonal Antibodies Sales (K Units) by Type (2023-2028)
Table 42. Global Monoclonal Antibodies Sales Share by Type (2023-2028)
Table 43. Global Monoclonal Antibodies Revenue (US$ Million) Market Share by Type (2023-2028)
Table 44. Global Monoclonal Antibodies Revenue Share by Type (2023-2028)
Table 45. Global Monoclonal Antibodies Price (K Units) by Type (2023-2028)
Table 46. Global Monoclonal Antibodies Sales (K Units) by Application (2017-2022)
Table 47. Global Monoclonal Antibodies Sales Share by Application (2017-2022)
Table 48. Global Monoclonal Antibodies Revenue (US$ Million) Market Share by Application (2017-2022)
Table 49. Global Monoclonal Antibodies Price (K Units) by Application (2017-2022)
Table 50. Global Monoclonal Antibodies Sales (K Units) by Application (2023-2028)
Table 51. Global Monoclonal Antibodies Sales Share by Application (2023-2028)
Table 52. Global Monoclonal Antibodies Revenue (US$ Million) Market Share by Application (2023-2028)
Table 53. Global Monoclonal Antibodies Revenue Share by Application (2023-2028)
Table 54. Global Monoclonal Antibodies Price (K Units) by Application (2023-2028)
Table 55. North America Monoclonal Antibodies Sales by Company (2017-2022) & (K Units)
Table 56. North America Monoclonal Antibodies Sales Market Share by Company (2017-2022)
Table 57. North America Monoclonal Antibodies Revenue by Company (2017-2022) & (US$ Million)
Table 58. North America Monoclonal Antibodies Revenue Market Share by Company (2017-2022)
Table 59. North America Monoclonal Antibodies Sales by Type (2017-2022) & (K Units)
Table 60. North America Monoclonal Antibodies Sales by Type (2023-2028) & (K Units)
Table 61. North America Monoclonal Antibodies Revenue by Type (2017-2022) & (US$ Million)
Table 62. North America Monoclonal Antibodies Revenue by Type (2023-2028) & (US$ Million)
Table 63. North America Monoclonal Antibodies Sales by Application (2017-2022) & (K Units)
Table 64. North America Monoclonal Antibodies Sales by Application (2023-2028) & (K Units)
Table 65. North America Monoclonal Antibodies Revenue by Application (2017-2022) & (US$ Million)
Table 66. North America Monoclonal Antibodies Revenue by Application (2023-2028) & (US$ Million)
Table 67. North America Monoclonal Antibodies Sales by Country (2017-2022) & (K Units)
Table 68. North America Monoclonal Antibodies Sales by Country (2023-2028) & (K Units)
Table 69. North America Monoclonal Antibodies Revenue by Country (2017-2022) & (US$ Million)
Table 70. North America Monoclonal Antibodies Revenue by Country (2023-2028) & (US$ Million)
Table 71. Europe Monoclonal Antibodies Sales by Company (2017-2022) & (K Units)
Table 72. Europe Monoclonal Antibodies Sales Market Share by Company (2017-2022)
Table 73. Europe Monoclonal Antibodies Revenue by Company (2017-2022) & (US$ Million)
Table 74. Europe Monoclonal Antibodies Revenue Market Share by Company (2017-2022)
Table 75. Europe Monoclonal Antibodies Sales by Type (2017-2022) & (K Units)
Table 76. Europe Monoclonal Antibodies Sales by Type (2023-2028) & (K Units)
Table 77. Europe Monoclonal Antibodies Revenue by Type (2017-2022) & (US$ Million)
Table 78. Europe Monoclonal Antibodies Revenue by Type (2023-2028) & (US$ Million)
Table 79. Europe Monoclonal Antibodies Sales by Application (2017-2022) & (K Units)
Table 80. Europe Monoclonal Antibodies Sales by Application (2023-2028) & (K Units)
Table 81. Europe Monoclonal Antibodies Revenue by Application (2017-2022) & (US$ Million)
Table 82. Europe Monoclonal Antibodies Revenue by Application (2023-2028) & (US$ Million)
Table 83. Europe Monoclonal Antibodies Sales by Country (2017-2022) & (K Units)
Table 84. Europe Monoclonal Antibodies Sales by Country (2023-2028) & (K Units)
Table 85. Europe Monoclonal Antibodies Revenue by Country (2017-2022) & (US$ Million)
Table 86. Europe Monoclonal Antibodies Revenue by Country (2023-2028) & (US$ Million)
Table 87. Asia Pacific Monoclonal Antibodies Sales by Company (2017-2022) & (K Units)
Table 88. Asia Pacific Monoclonal Antibodies Sales Market Share by Company (2017-2022)
Table 89. Asia Pacific Monoclonal Antibodies Revenue by Company (2017-2022) & (US$ Million)
Table 90. Asia Pacific Monoclonal Antibodies Revenue Market Share by Company (2017-2022)
Table 91. Asia Pacific Monoclonal Antibodies Sales by Type (2017-2022) & (K Units)
Table 92. Asia Pacific Monoclonal Antibodies Sales by Type (2023-2028) & (K Units)
Table 93. Asia Pacific Monoclonal Antibodies Revenue by Type (2017-2022) & (US$ Million)
Table 94. Asia Pacific Monoclonal Antibodies Revenue by Type (2023-2028) & (US$ Million)
Table 95. Asia Pacific Monoclonal Antibodies Sales by Application (2017-2022) & (K Units)
Table 96. Asia Pacific Monoclonal Antibodies Sales by Application (2023-2028) & (K Units)
Table 97. Asia Pacific Monoclonal Antibodies Revenue by Application (2017-2022) & (US$ Million)
Table 98. Asia Pacific Monoclonal Antibodies Revenue by Application (2023-2028) & (US$ Million)
Table 99. Asia Pacific Monoclonal Antibodies Sales by Region (2017-2022) & (K Units)
Table 100. Asia Pacific Monoclonal Antibodies Sales by Region (2023-2028) & (K Units)
Table 101. Asia Pacific Monoclonal Antibodies Revenue by Region (2017-2022) & (US$ Million)
Table 102. Asia Pacific Monoclonal Antibodies Revenue by Region (2023-2028) & (US$ Million)
Table 103. Latin America Monoclonal Antibodies Sales by Company (2017-2022) & (K Units)
Table 104. Latin America Monoclonal Antibodies Sales Market Share by Company (2017-2022)
Table 105. Latin America Monoclonal Antibodies Revenue by Company (2017-2022) & (US$ Million)
Table 106. Latin America Monoclonal Antibodies Revenue Market Share by Company (2017-2022)
Table 107. Latin America Monoclonal Antibodies Sales by Type (2017-2022) & (K Units)
Table 108. Latin America Monoclonal Antibodies Sales by Type (2023-2028) & (K Units)
Table 109. Latin America Monoclonal Antibodies Revenue by Type (2017-2022) & (US$ Million)
Table 110. Latin America Monoclonal Antibodies Revenue by Type (2023-2028) & (US$ Million)
Table 111. Latin America Monoclonal Antibodies Sales by Application (2017-2022) & (K Units)
Table 112. Latin America Monoclonal Antibodies Sales by Application (2023-2028) & (K Units)
Table 113. Latin America Monoclonal Antibodies Revenue by Application (2017-2022) & (US$ Million)
Table 114. Latin America Monoclonal Antibodies Revenue by Application (2023-2028) & (US$ Million)
Table 115. Latin America Monoclonal Antibodies Sales by Country (2017-2022) & (K Units)
Table 116. Latin America Monoclonal Antibodies Sales by Country (2023-2028) & (K Units)
Table 117. Latin America Monoclonal Antibodies Revenue by Country (2017-2022) & (US$ Million)
Table 118. Latin America Monoclonal Antibodies Revenue by Country (2023-2028) & (US$ Million)
Table 119. Middle East and Africa Monoclonal Antibodies Sales by Company (2017-2022) & (K Units)
Table 120. Middle East and Africa Monoclonal Antibodies Sales Market Share by Company (2017-2022)
Table 121. Middle East and Africa Monoclonal Antibodies Revenue by Company (2017-2022) & (US$ Million)
Table 122. Middle East and Africa Monoclonal Antibodies Revenue Market Share by Company (2017-2022)
Table 123. Middle East and Africa Monoclonal Antibodies Sales by Type (2017-2022) & (K Units)
Table 124. Middle East and Africa Monoclonal Antibodies Sales by Type (2023-2028) & (K Units)
Table 125. Middle East and Africa Monoclonal Antibodies Revenue by Type (2017-2022) & (US$ Million)
Table 126. Middle East and Africa Monoclonal Antibodies Revenue by Type (2023-2028) & (US$ Million)
Table 127. Middle East and Africa Monoclonal Antibodies Sales by Application (2017-2022) & (K Units)
Table 128. Middle East and Africa Monoclonal Antibodies Sales by Application (2023-2028) & (K Units)
Table 129. Middle East and Africa Monoclonal Antibodies Revenue by Application (2017-2022) & (US$ Million)
Table 130. Middle East and Africa Monoclonal Antibodies Revenue by Application (2023-2028) & (US$ Million)
Table 131. Middle East and Africa Monoclonal Antibodies Sales by Country (2017-2022) & (K Units)
Table 132. Middle East and Africa Monoclonal Antibodies Sales by Country (2023-2028) & (K Units)
Table 133. Middle East and Africa Monoclonal Antibodies Revenue by Country (2017-2022) & (US$ Million)
Table 134. Middle East and Africa Monoclonal Antibodies Revenue by Country (2023-2028) & (US$ Million)
Table 135. Biocon Corporation Information
Table 136. Biocon Description and Overview
Table 137. Biocon Monoclonal Antibodies Sales (K Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2017-2022)
Table 138. Biocon Monoclonal Antibodies Product and Services
Table 139. Biocon Monoclonal Antibodies SWOT Analysis
Table 140. Biocon Recent Developments
Table 141. Celltrion Corporation Information
Table 142. Celltrion Description and Overview
Table 143. Celltrion Monoclonal Antibodies Sales (K Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2017-2022)
Table 144. Celltrion Monoclonal Antibodies Product and Services
Table 145. Celltrion Monoclonal Antibodies SWOT Analysis
Table 146. Celltrion Recent Developments
Table 147. Dr. Reddy's Laboratories Corporation Information
Table 148. Dr. Reddy's Laboratories Description and Overview
Table 149. Dr. Reddy's Laboratories Monoclonal Antibodies Sales (K Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2017-2022)
Table 150. Dr. Reddy's Laboratories Monoclonal Antibodies Product and Services
Table 151. Dr. Reddy's Laboratories Monoclonal Antibodies SWOT Analysis
Table 152. Dr. Reddy's Laboratories Recent Developments
Table 153. Hospira Corporation Information
Table 154. Hospira Description and Overview
Table 155. Hospira Monoclonal Antibodies Sales (K Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2017-2022)
Table 156. Hospira Monoclonal Antibodies Product and Services
Table 157. Hospira Monoclonal Antibodies SWOT Analysis
Table 158. Hospira Recent Developments
Table 159. 3SBio Corporation Information
Table 160. 3SBio Description and Overview
Table 161. 3SBio Monoclonal Antibodies Sales (K Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2017-2022)
Table 162. 3SBio Monoclonal Antibodies Product and Services
Table 163. 3SBio Monoclonal Antibodies SWOT Analysis
Table 164. 3SBio Recent Developments
Table 165. Accord Healthcare Corporation Information
Table 166. Accord Healthcare Description and Overview
Table 167. Accord Healthcare Monoclonal Antibodies Sales (K Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2017-2022)
Table 168. Accord Healthcare Monoclonal Antibodies Product and Services
Table 169. Accord Healthcare Monoclonal Antibodies SWOT Analysis
Table 170. Accord Healthcare Recent Developments
Table 171. AET Biotech Corporation Information
Table 172. AET Biotech Description and Overview
Table 173. AET Biotech Monoclonal Antibodies Sales (K Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2017-2022)
Table 174. AET Biotech Monoclonal Antibodies Product and Services
Table 175. AET Biotech Monoclonal Antibodies SWOT Analysis
Table 176. AET Biotech Recent Developments
Table 177. Allergan Corporation Information
Table 178. Allergan Description and Overview
Table 179. Allergan Monoclonal Antibodies Sales (K Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2017-2022)
Table 180. Allergan Monoclonal Antibodies Product and Services
Table 181. Allergan Monoclonal Antibodies SWOT Analysis
Table 182. Allergan Recent Developments
Table 183. Amega Biotech Corporation Information
Table 184. Amega Biotech Description and Overview
Table 185. Amega Biotech Monoclonal Antibodies Sales (K Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2017-2022)
Table 186. Amega Biotech Monoclonal Antibodies Product and Services
Table 187. Amega Biotech Monoclonal Antibodies SWOT Analysis
Table 188. Amega Biotech Recent Developments
Table 189. Key Raw Materials Lists
Table 190. Raw Materials Key Suppliers Lists
Table 191. Monoclonal Antibodies Distributors List
Table 192. Monoclonal Antibodies Customers List
Table 193. Research Programs/Design for This Report
Table 194. Key Data Information from Secondary Sources
Table 195. Key Data Information from Primary Sources
List of Figures
Figure 1. Monoclonal Antibodies Product Picture
Figure 2. Global Monoclonal Antibodies Sales Market Share by Type in 2021 & 2028
Figure 3. Erythropoietin (EPO) Product Picture
Figure 4. Human Growth Hormone (HGH) Product Picture
Figure 5. Granulocyte- Colony Stimulating Factor (G-CSF) Product Picture
Figure 6. Monoclonal Antibody (mAb) Product Picture
Figure 7. Insulin Product Picture
Figure 8. Interferon (IFN) Product Picture
Figure 9. Others Product Picture
Figure 10. Global Monoclonal Antibodies Sales Market Share by Application in 2021 & 2028
Figure 11. Anti-Cancer Use Case
Figure 12. Anti-Inflammatory/Autoimmune Use Case
Figure 13. Monoclonal Antibodies Report Years Considered
Figure 14. Global Monoclonal Antibodies Revenue, (US$ Million), 2017 VS 2021 VS 2028
Figure 15. Global Monoclonal Antibodies Market Size 2017-2028 (US$ Million)
Figure 16. Global Monoclonal Antibodies Sales (2017-2022) & (K Units)
Figure 17. Global Monoclonal Antibodies Market Size Market Share by Region: 2021 VS 2028
Figure 18. Global Monoclonal Antibodies Sales Market Share by Region (2017-2022)
Figure 19. Global Monoclonal Antibodies Sales Market Share by Region in 2021
Figure 20. Global Monoclonal Antibodies Revenue Market Share by Region in 2017 VS 2021
Figure 21. Global Monoclonal Antibodies Sales Share by Manufacturers in 2021
Figure 22. The 5 and 10 Largest Manufacturers in the World: Market Share by Monoclonal Antibodies Sales in 2021
Figure 23. Monoclonal Antibodies Revenue Share by Manufacturers in 2021
Figure 24. Monoclonal Antibodies Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2017 VS 2021
Figure 25. Global Monoclonal Antibodies Revenue Share by Type (2017-2022)
Figure 26. Global Monoclonal Antibodies Revenue Growth Rate by Type in 2017 & 2021
Figure 27. Globa
  • Global Antibody Market Growth 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 136
    According to our LPI (LP Information) latest study, the global Antibody market size was valued at US$ 8893.3 million in 2023. With growing demand in downstream market, the Antibody is forecast to a readjusted size of US$ 12940 million by 2030 with a CAGR of 5.5% during review period. The research report highlights the growth potential of the global Antibody market. Antibody are expected to show stable growth in the future market. However, product differentiation, reducing costs, and supp......
  • Global Antibody Production Market Status and Outlook 2023-2028
    Published: 22-Dec-2023        Price: US 3160 Onwards        Pages: 121
    Antibody production involves preparation of antigen samples and their safe injection into laboratory or farm animals so as to evoke high expression levels of antigen-specific antibodies in the serum, which can then be recovered from the animal. Polyclonal antibodies are recovered directly from serum (bleeds). Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market value (mil......
  • Global Antibody Production Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028
    Published: 21-Dec-2023        Price: US 3380 Onwards        Pages: 100
    Market Overview of Global Antibody Production market: According to our latest research, the global Antibody Production market looks promising in the next 5 years. As of 2022, the global Antibody Production market was estimated at USD 9193.37 million, and it's anticipated to reach USD 17140.24 million in 2028, with a CAGR of 10.94% during the forecast years. This report covers a research time span from 2018 to 2028, and presents a deep and comprehensive analysis of the global ......
  • Global Antibody Production Market Research Report 2024 (Status and Outlook)
    Published: 15-Dec-2023        Price: US 3200 Onwards        Pages: 117
    Report Overview: The Global Antibody Production Market Size was estimated at USD 8847.90 million in 2022 and is projected to reach USD 14207.79 million by 2029, exhibiting a CAGR of 7.00% during the forecast period. This report provides a deep insight into the global Antibody Production market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key mark......
  • Global Anti-CD20 Monoclonal Antibodies Professional Survey Report 2023, Forecast to 2028
    Published: 30-Nov-2023        Price: US 3280 Onwards        Pages: 100
    Anti-CD20 monoclonal antibodies (mAbs) are used to achieve B cell depletion, and were initially developed to treat B cell proliferative disorders, including non-Hodgkin's lymphoma (NHL) and chronic lymphocytic leukemia (CLL). Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market value (million USD) data for each segment and sub-segment. This way, clients can achieve all th......
  • Global Anti-CD20 Monoclonal Antibodies Market Research Report 2023, Forecast to 2028
    Published: 30-Nov-2023        Price: US 2680 Onwards        Pages: 165
    Anti-CD20 monoclonal antibodies (mAbs) are used to achieve B cell depletion, and were initially developed to treat B cell proliferative disorders, including non-Hodgkin's lymphoma (NHL) and chronic lymphocytic leukemia (CLL). Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market value (million USD) data for each segment and sub-segment. This way, clients can achieve all th......
  • Monoclonal Antibody Industry Forecasts - China Focus
    Published: 27-Nov-2023        Price: US 1800 Onwards        Pages: 92
    This study focuses on China's Monoclonal Antibody industry forecasts. In the two past decades, the industry has been growing at a fast pace. The dramatic expansions of the manufacturing capabilities and rising consumer consumptions in China have transformed China's society and economy. China is one of the world's major producers for industrial and consumer products. Far outpacing other economies in the world, China is the world's fastest growing market for the consumptions of goods and services.......
  • Monoclonal Antibody Companies in China
    Published: 27-Nov-2023        Price: US 1800 Onwards        Pages: 73
    This study focuses on China's Monoclonal Antibody industry assessments and company profiles. In the two past decades, the industry has been growing at a fast pace. The dramatic expansions of the manufacturing capabilities and rising consumer consumptions in China have transformed China's society and economy. China is one of the world's major producers for industrial and consumer products. Far outpacing other economies in the world, China is the world's fastest growing market for the consumptions......
  • Monoclonal Antibody Markets in China
    Published: 27-Nov-2023        Price: US 4000 Onwards        Pages: 219
    China's demand for Monoclonal Antibody has grown at a fast pace in the past decade. In the next decade, both production and demand will continue to grow. The Chinese economy maintains a high speed growth which has been stimulated by the consecutive increases of industrial output, imports & exports, consumer consumption and capital investment for over two decades. This new study examines China's economic trends, investment environment, industry development, supply and demand, industry capacity, i......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs